Research Highlight | Published:

IMMUNOTHERAPY

Glioblastoma is ‘hot’ for personalized vaccines

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

    Original articles

    1. Hilf, N. et al. Actively personalized vaccination trial for newly diagnosed glioblastoma. Nature 565, 240–245 (2019)

    2. Keskin, D. B. et al. Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial. Nature 565, 234–239 (2019)

    Download references

    Author information

    Correspondence to Maria Giuseppina Baratta.

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark